Share on StockTwits

Cross Country Healthcare (NASDAQ:CCRN) Insider Paul Tymchuk purchased 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The shares were purchased at an average price of $6.64 per share, for a total transaction of $19,920.00. Following the completion of the transaction, the insider now directly owns 51,498 shares of the company’s stock, valued at approximately $341,947. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Separately, analysts at Zacks downgraded shares of Cross Country Healthcare from a “neutral” rating to an “underperform” rating in a research note on Monday, May 12th. They now have a $5.40 price target on the stock.

Shares of Cross Country Healthcare (NASDAQ:CCRN) traded down 1.33% on Tuesday, hitting $6.68. The stock had a trading volume of 276,811 shares. Cross Country Healthcare has a 1-year low of $4.83 and a 1-year high of $11.54. The stock’s 50-day moving average is $6.26 and its 200-day moving average is $8.37. The company’s market cap is $207.8 million.

Cross Country Healthcare (NASDAQ:CCRN) last announced its earnings results on Wednesday, May 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.02. The company had revenue of $118.10 million for the quarter, compared to the consensus estimate of $120.21 million. During the same quarter in the previous year, the company posted ($0.01) earnings per share. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Analysts expect that Cross Country Healthcare will post $0.05 EPS for the current fiscal year.

Cross Country Healthcare, Inc (NASDAQ:CCRN) is engaged in the healthcare staffing services business offering a suite staffing and outsourcing services to the healthcare market.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.